StockData
Takeda Pharmaceutical Co Ltd logo

Takeda Pharmaceutical Co Ltd (TKPHF) stock

TKPHFOTCPharmaceutical PreparationsAlso trades as TAK
Financials through fiscal 2026, year ended Mar 31, 2026Last filing: 20-F on Jun 17, 2026Score 5/30
$39.00+0.36 (+0.93%)

Close on Oct 19, 2026Market cap $134.41BP/E –Yield –

Takeda Pharmaceutical statistics

91 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.

Important dates

Next earnings
–
Last ex-dividend date
Sep 29, 2026
Fundamentals through
Mar 31, 2026
Share price as of
–

Valuation ratiosIndustry

Market Cap
¥11.30T
–
Enterprise Value
¥15.59T
–
PS Ratio
2.51
–
PB Ratio
1.52
–
P/FCF Ratio
13.06
–
P/OCF Ratio
10.85
–

Enterprise valuationIndustry

EV / Sales
3.46
–
EV / EBITDA
21.44
–
EV / EBIT
2508.02
–
EV / FCF
18.02
–

Share statisticsIndustry

Shares Change (YoY)
-1.89%
–
Float
1.72B
–
Shares Held by Insiders
0.22%
–
Shares Held by Institutions
6.05%
–

Short sellingIndustry

Short Interest
3M
–
Short Interest Change
-30.6%
–
Days to Cover
1.19
–

Stock price statisticsIndustry

Price Change (1 Week)
3.31%
–
Price Change (1 Month)
17.1%
–
Price Change (3 Months)
24.2%
–
Price Change (6 Months)
25.8%
–
Price Change (YTD)
34.1%
–
Price Change (1 Year)
51.9%
–
Price Change (3 Years)
53.8%
–
Price Change (5 Years)
49.1%
–
Price Change (10 Years)
-6.86%
–
Average Volume (10 Days)
3M
–
Average Volume (20 Days)
3M
–
Average Volume (90 Days)
3M
–
Relative Volume
1.54
–
Relative Strength Index (14)
71.9
–
Volatility (1 Year)
21.7%
–
Beta (5 Years)
0.22
–

MarginsIndustry

Gross Margin
65.1%
–
Pretax Margin
-3.16%
–
Profit Margin
-3.38%
–
EBITDA Margin
16.1%
–
FCF Margin
19.2%
–

Returns on capitalIndustry

Return on Equity (ROE)
-2.12%
–
Return on Assets (ROA)
-1.02%
–
Return on Invested Capital (ROIC)
0.04%
–
Return on Capital Employed (ROCE)
0.05%
–

Financial positionIndustry

Current Ratio
1.09
–
Quick Ratio
0.51
–
Debt / Equity
0.66
–
Debt / EBITDA
6.71
–
Debt / FCF
5.64
–
Net Debt / EBITDA
5.89
–
Interest Coverage
0.02
–

GrowthIndustry

Revenue Growth (YoY)
-1.66%
–
Net Income Growth (YoY)
-241.2%
–
EPS Growth (YoY)
-243.9%
–
FCF Growth (YoY)
1.06%
–
Revenue Growth (3Y CAGR)
3.81%
–
Revenue Growth (5Y CAGR)
7.10%
–

EfficiencyIndustry

Asset Turnover
0.30
–
Inventory Turnover
1.20
–
Revenue Per Employee
¥95.87M
–
Profits Per Employee
-¥3.24M
–
Employee Count
47,000
–
WACC
6.97%
–

Income statement (TTM)Industry

Revenue
¥4.51T
–
Gross Profit
¥2.93T
–
Pretax Income
-¥142.36B
–
Net Income
-¥152.39B
–
EBITDA
¥727.34B
–
EPS (Diluted)
-96.75 JPY
–

Balance sheetIndustry

Total Debt
¥4.88T
–
Net Cash (Debt)
-¥4.29T
–
Net Cash Per Share
-2487.76 JPY
–
Equity (Book Value)
¥7.43T
–
Book Value Per Share
4311.55 JPY
–
Tangible Book Value
-¥1.80T
–
Working Capital
¥258.43B
–

Cash flow (TTM)Industry

Capital Expenditures
-¥176.00B
–
Free Cash Flow
¥865.43B
–
FCF Per Share
502.24 JPY
–

Dividends and yieldsIndustry

Earnings Yield
-1.35%
–
FCF Yield
7.66%
–
Buyback Yield
0.46%
–
Shareholder Yield
0.46%
–
FCF Payout Ratio
36.0%
–

Taxes and interestIndustry

Interest Expense
¥357.57B
–
Income Tax
¥9.77B
–

Scores and fair valueIndustry

Altman Z-Score
1.22
–
Piotroski F-Score
5
–

Total return vs. the S&P 500

Price change plus reinvested dividends, to the close on Oct 19, 2026. The S&P 500 is measured by the SPY fund.

PeriodTKPHFS&P 500DifferenceTKPHF per yearS&P 500 per year
1 month+4.5%+0.6%+3.8 pts
3 months+14.4%+3.4%+11.0 pts
Year to date+31.1%+13.3%+17.8 pts
1 year+39.2%+16.6%+22.5 pts
3 years+49.9%+86.4%−36.5 pts+14.4%+23.1%
5 years+74.0%+81.9%−7.8 pts+11.7%+12.7%
10 years+28.5%+318.9%−290.4 pts+2.5%+15.4%

Short interest

Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 15, 2026.

3M TKPHF shares were sold short on Oct 15, 2026, down 2.9% from the previous report. At recent volumes it would take 716.8 days to buy them back.

Settlement dateShares shortChangeAvg. daily volumeDays to cover
Oct 15, 20262,612,562-2.9%3,645716.8
Sep 30, 20262,691,785+19.6%22,091121.8
Sep 15, 20262,250,395-43.8%3451000.0
Aug 31, 20264,001,199+23.6%60,38766.3
Aug 14, 20263,237,586+155.5%52,04862.2
Jul 31, 20261,267,191+22.3%53,30523.8
Jul 15, 20261,035,804-7.5%49,46320.9
Jun 30, 20261,119,591+3.8%12,02893.1
Jun 15, 20261,078,669-13.2%27,01139.9
May 29, 20261,242,467-46.0%18,81066.0
May 15, 20262,300,008+77.0%91,62525.1
Apr 30, 20261,299,130+11.9%28,29045.9

Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.